Relmada Therapeutics, Inc. Share Price
RLMDRelmada Therapeutics, Inc. Stock Performance
Open $3.35 | Prev. Close $3.30 | Circuit Range N/A |
Day Range $3.35 - $3.83 | Year Range $0.24 - $3.83 | Volume 23,368 |
Average Traded $3.71 |
Relmada Therapeutics, Inc. Share Price Chart
About Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. It also develops REL-P11, a modified-release formulation of psilocybin that has completed Phase 1 safety study for the treatment of metabolic disease. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Relmada Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
11-Nov-25 | $3.01 | $3.29 | +9.12% |
10-Nov-25 | $2.75 | $3.02 | +13.77% |
07-Nov-25 | $2.53 | $2.65 | +1.53% |
06-Nov-25 | $2.86 | $2.61 | +3.57% |
05-Nov-25 | $2.57 | $2.52 | -9.84% |
04-Nov-25 | $2.21 | $2.79 | +26.47% |
03-Nov-25 | $2.19 | $2.21 | -0.45% |
FAQs on Relmada Therapeutics, Inc. Share Price
Can I buy Relmada Therapeutics, Inc. shares in India?
What is the share price of Relmada Therapeutics, Inc.?
What is the 5 year returns of Relmada Therapeutics, Inc.?
What are the high & low stock price of Relmada Therapeutics, Inc. today?
What is the 52-week high and low of Relmada Therapeutics, Inc. stock?